Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
暂无分享,去创建一个
A. Haese* | H. Lilja | M. Graefen | H. Huland | J. Noldus | H Lilja | H Huland | C Becker | M Graefen | A Haese | J Noldus | E Huland | C. Becker | E. Huland | Hartwig Huland | Hans Lilja | A. Haese | Joachim Noldus | Edith Huland
[1] R. Wolfert,et al. The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia. , 1998, Clinical chemistry.
[2] J. Oesterling,et al. The clinical usefulness of prostate specific antigen: update 1994. , 1994, The Journal of urology.
[3] A. Schaeffer,et al. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. , 1999, The Journal of urology.
[4] M. Hara,et al. [Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII]. , 1971, Nihon hoigaku zasshi = The Japanese journal of legal medicine.
[5] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[6] M. Benson,et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.
[7] G. Murakami,et al. Anatomical studies of the autonomic nervous system in the human pelvis by the whole-mount staining method: left-right communicating nerves between bilateral pelvic plexuses. , 1999, The Journal of urology.
[8] R. Vessella,et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.
[9] O. Nilsson,et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. , 1991, Clinical chemistry.
[10] O. Nilsson,et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.
[11] T. Piironen,et al. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL. , 1998, Urology.
[12] H. Lilja,et al. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. , 1996, Clinical chemistry.
[13] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[14] H. Lilja,et al. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate‐specific antigen , 1997, The Prostate.
[15] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.
[16] D. Tindall,et al. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. , 1992, Biochemistry.
[17] A. Rademaker,et al. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.
[18] H. Lilja,et al. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. , 1997, Biochemical and biophysical research communications.
[19] G. Paradis,et al. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate‐specific antigen , 1988, FEBS letters.
[20] U. Stenman,et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.
[21] C G Chute,et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.
[22] R. Vessella,et al. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. , 1997, Urology.
[23] Myron Tanncnbaum,et al. Urologic pathology: The prostate , 1977 .
[24] J. Oesterling,et al. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.
[25] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[26] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[27] A W Partin,et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.
[28] J. Oesterling,et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.
[29] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.
[30] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[31] G G Klee,et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. , 1997, Urology.
[32] T. Piironen,et al. VARIOUS RATIOS OF HUMAN GLANDULAR KALLIKREIN (HK2) TO FREE AND TOTAL PSA IMPROVE DISCRIMINATION BETWEEN G1-G2 AND G3 PROSTATE TUMORS , 1999 .
[33] R. Wolfert,et al. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. , 1998, Urology.
[34] D. Tindall,et al. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. , 1993, Biochemistry.
[35] D. Tindall,et al. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. , 1997, Urology.